Table 2.
Hypertension | Artery Smooth Muscle | Reference | |||
---|---|---|---|---|---|
NCX1 | ROC | ||||
TRPC3 | TRPC6 | ||||
1 | Ouabain* (vs vehicle & digoxin) | ↑ | ↑ | (Pulina et al., 2010b; Zulian et al., 2010b) |
|
2 | DOCA-salt* | ND** | ↑ | (Bae et al., 2007) | |
3 | Milan hypertension* (vs Milan NT)** | ↑ | ↑ | (Zulian et al., 2010a) | |
4 | SHR (vs WKY)** | ↑ | ↑ | (Taniguchi et al., 2004; Liu et al., 2009) | |
5 | Dahl salt-sensitive/high (vs low) salt* | ↑ | ↑ | VA Golovina (unpublished) | |
6 | NCX1SM.Tg/Tg ** | ↑ | ↑ | (Iwamoto et al., 2004); J Zhang & MP Blaustein (unpublished) |
|
7 | Angiotensin II | ↑ | ND** | L Chen, M Li & MP Blaustein (unpublished) |
|
8 | Human primary pulmonary hypertension | ↑ | ↑ | ↑ | (Yu et al., 2004; Zhang et al., 2007a; Zhang et al., 2007b) |
Hypertension associated with elevated plasma ouabain levels.
Not determined.
Abbreviations: NT, normotensive control; SHR, spontaneously hypertensive rat; WKY, Wistar-Kyoto normotensive control for SHR; NCX1SMTg/Tg, smooth muscle-specific NCX1 knockout mouse (Zhang et al., 2010).